Penbrook Management LLC Decreases Holdings in Axcelis Technologies, Inc. $ACLS

Penbrook Management LLC decreased its stake in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 23.9% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,095 shares of the semiconductor company’s stock after selling 3,800 shares during the period. Penbrook Management LLC’s holdings in Axcelis Technologies were worth $1,126,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ACLS. Louisiana State Employees Retirement System purchased a new stake in shares of Axcelis Technologies during the 1st quarter worth approximately $1,266,000. Evolve Private Wealth LLC raised its holdings in shares of Axcelis Technologies by 9.6% in the 1st quarter. Evolve Private Wealth LLC now owns 7,706 shares of the semiconductor company’s stock worth $717,000 after purchasing an additional 677 shares during the period. Rockefeller Capital Management L.P. lifted its stake in Axcelis Technologies by 69.2% in the fourth quarter. Rockefeller Capital Management L.P. now owns 1,357 shares of the semiconductor company’s stock valued at $109,000 after purchasing an additional 555 shares during the last quarter. Corient Private Wealth LLC lifted its stake in Axcelis Technologies by 4.0% in the fourth quarter. Corient Private Wealth LLC now owns 5,792 shares of the semiconductor company’s stock valued at $466,000 after purchasing an additional 222 shares during the last quarter. Finally, Invesco Ltd. lifted its stake in Axcelis Technologies by 23.8% in the fourth quarter. Invesco Ltd. now owns 478,897 shares of the semiconductor company’s stock valued at $38,475,000 after purchasing an additional 92,162 shares during the last quarter. 89.98% of the stock is currently owned by hedge funds and other institutional investors.

Axcelis Technologies Stock Performance

Shares of ACLS stock opened at $180.70 on Friday. The firm’s 50 day moving average is $155.80 and its 200 day moving average is $112.74. The stock has a market capitalization of $5.55 billion, a P/E ratio of 56.29, a PEG ratio of 11.96 and a beta of 1.91. Axcelis Technologies, Inc. has a 12 month low of $65.64 and a 12 month high of $193.78. The company has a current ratio of 4.59, a quick ratio of 2.99 and a debt-to-equity ratio of 0.04.

Axcelis Technologies (NASDAQ:ACLS) last released its quarterly earnings data on Thursday, May 7th. The semiconductor company reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. Axcelis Technologies had a net margin of 11.93% and a return on equity of 12.19%. The business had revenue of $198.96 million during the quarter, compared to analyst estimates of $195.03 million. During the same period in the previous year, the business earned $0.88 EPS. Axcelis Technologies’s revenue was up 3.3% compared to the same quarter last year. Axcelis Technologies has set its Q2 2026 guidance at 0.900- EPS. On average, sell-side analysts anticipate that Axcelis Technologies, Inc. will post 3.21 earnings per share for the current year.

Insider Buying and Selling

In other Axcelis Technologies news, Director John T. Kurtzweil sold 3,500 shares of the firm’s stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $138.79, for a total value of $485,765.00. Following the completion of the transaction, the director owned 32,990 shares in the company, valued at $4,578,682.10. This trade represents a 9.59% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Russell Low sold 7,468 shares of the firm’s stock in a transaction dated Wednesday, May 6th. The stock was sold at an average price of $156.75, for a total value of $1,170,609.00. Following the completion of the transaction, the chief executive officer owned 123,570 shares of the company’s stock, valued at approximately $19,369,597.50. This represents a 5.70% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 36,039 shares of company stock valued at $5,461,394 in the last 90 days. Corporate insiders own 0.49% of the company’s stock.

Analyst Ratings Changes

A number of analysts have issued reports on ACLS shares. Bank of America raised their target price on Axcelis Technologies from $130.00 to $156.00 and gave the stock an “underperform” rating in a research report on Tuesday. B. Riley Financial raised Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 price target on the stock in a research report on Monday, April 20th. Zacks Research upgraded Axcelis Technologies from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. Finally, Weiss Ratings lowered Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday, May 12th. Three research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $130.25.

About Axcelis Technologies

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.